|
Pma 510k #p050017/s002 and s003.Device evaluation: off label use complaints are considered to be unforeseen misuse.It is unknown how the device will function outside of its intended use.Trending will monitor if any future investigation is required.The ziv6-35-125-8-80 device of lot number c1920965 was returned for evaluation, with the original packaging at a later date.The file was sent back to investigation in progress and the investigation was updated accordingly.With the information provided, a physical examination and document-based investigation was conducted.This complaint is related to pr (b)(4) which was raised to capture the off label use of the replacement device.Numerous attempts were made to obtain the rpn and the lot number of the replacement device, as well as additional information regarding the complaint, but no further information was received.Should any further information become available at a later date, the file can be re-opened and updated accordingly.The device related to this occurrence underwent a laboratory evaluation on the (b)(6) 2023.Refer to the returned product-notes field for lab attendance and lab evaluation notes.The returned device lab examination findings and observations can be referred through attached photos.On evaluation of the device the following was noted: visual inspection: device returned with additional components that are not supplied with this device.Red safety tab still in place.Functional inspection: device flushed with no issue.0.035¿¿ wireguide passed with no issue.Stent deployed with no issue.Stent intact.Manufacturing records prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records did not reveal any discrepancies that could have contributed to this complaint issue.Ifu/label review it should be noted that the instructions for use (ifu0043) states the following: ¿intended for use as an adjunct to percutaneous transluminal angioplasty (pta) in the treatment of symptomatic vascular disease of the iliac arteries¿.There is evidence to suggest that the customer did not follow the instructions for use.Image review an image was not returned for evaluation.Root cause analysis a definitive root cause of off label use was established.The user has not complied with the requirements of the ifu with respect to the intended use of the device.The intended area for use is the iliac arteries yet the device was used during a transverse sinus stenting procedure.It should be noted that, as the device was used outside of their validated state and/or against the instructions provided in the ifu, it is not possible to predict how the devices will perform or function.Confirmation of complaint as the complaint claim may have been influenced by clinical settings that cannot be replicated or verified, the complaint is confirmed based on customer and/or rep testimony.Summary according to the initial reporter, the physician was stenting a venous transverse sinus and the shuttle would not pull back.The stent delivery was through the shuttle.They had to pull everything out over the wire leaving the wire in place.He put a new shuttle in and a new stent and everything went fine on the second attempt.Confirmed quantity of 01 device, confirmed used.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.He put a new shuttle in and a new stent and everything went fine on the second attempt.The off label use of the replacement device is captured under pr (b)(4).Investigation findings conclude that a definitive root cause was established.The user has not complied with the requirements of the ifu with respect to the intended use of the device.From the information provided it is known that the device was being used during a venous transverse sinus stenting.This device intended area of use is the iliac arteries as per ifu "intended for use as an adjunct to percutaneous transluminal angioplasty (pta) in the treatment of symptomatic vascular disease of the iliac arteries¿.As per (b)(4), rev006, section 5.3 table 1 - off label use complaints are considered to be unforeseen misuse.It is unknown how the device will function outside of its intended use.The user used this device outside of its intended and validated area of use.The complaint is confirmed based on customer and/or rep testimony.Complaints of this nature will continue to be monitored for potential emerging trends.
|